Is Zepbound as Effective as Mounjaro for Weight Loss?

Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Zepbound (semaglutide) and Mounjaro (tirzepatide) are both FDA-approved medications that lower blood sugar and promote weight loss, but they work through different hormone pathways in your body. Tirzepatide targets two receptors—GLP-1 and GIP—while semaglutide targets only GLP-1, which explains why clinical trials show tirzepatide producing numerically greater weight reductions in some populations. Choosing between them depends on your individual metabolism, genetic response patterns, and treatment goals.

How Zepbound and Mounjaro Work Differently

Zepbound (semaglutide) activates the glucagon-like peptide-1 receptor, which signals your brain to feel fuller longer and slows stomach emptying. This single-receptor approach has been studied extensively, with clinical trials documenting sustained weight loss of 15–22% over 68 weeks in patients with obesity. The medication also improves insulin sensitivity and reduces cardiovascular risk in people with type 2 diabetes.

Mounjaro (tirzepatide) engages both the GLP-1 receptor and the GIP receptor simultaneously. The dual-receptor activation may amplify appetite suppression and metabolic changes more potently than semaglutide alone. In head-to-head trial comparisons, tirzepatide-treated participants achieved weight losses ranging from 20–22% at the highest doses, with some subgroups showing reductions exceeding 25% of baseline body weight.

Clinical Trial Results: Weight Loss Comparison

The STEP trials (Zepbound) enrolled over 4,500 participants across multiple studies and demonstrated consistent weight reductions of 15–22% depending on the specific trial and dose used. These results were sustained over 68 weeks, and many participants maintained weight loss during a follow-up period. Safety profiles in the trials included gastrointestinal side effects as the most common adverse events, typically mild to moderate and dose-dependent.

The SURPASS trials (Mounjaro) included more than 8,000 participants and showed that tirzepatide achieved numerically higher weight losses, with some trials reporting reductions of 20–22% and others showing even greater effects in certain dosing arms. When SURPASS-2 directly compared tirzepatide to semaglutide in people with type 2 diabetes, tirzepatide demonstrated superior glycemic control and greater weight loss, though both were well-tolerated overall.

Genetic Factors That Influence Your Response

Not every person responds identically to the same medication because genetic variations affect how your body processes these compounds and how your receptors function. For example, genetic variants in the GLP1R gene (like rs6923761) influence receptor sensitivity, while GIPR variants (such as rs1800437) affect how efficiently your body responds to GIP signaling. Individuals with certain variants may experience more pronounced appetite suppression or metabolic benefits from one medication over the other.

PlexusDx offers the Precision Peptide Genetic Test, which maps 14 metabolic pathways and analyzes 49 peptides involved in weight regulation to identify your genetic predispositions. Understanding variants in genes like FTO, MC4R, and GLP1R can help clarify which medication class—single-receptor or dual-receptor—may align better with your biological response profile. This personalized insight supports more confident treatment selection and dose optimization.

Which Medication Is Right for You?

Choosing between Zepbound (semaglutide) and Mounjaro (tirzepatide) depends on your weight loss targets, tolerance for side effects, existing health conditions, and individual response patterns. Some patients prefer starting with semaglutide because it has a longer clinical history and a well-established tolerability profile. Others benefit from tirzepatide's dual-receptor action if they need more aggressive appetite suppression or have specific metabolic markers indicating a stronger GIP pathway response.

PlexusDx provides compounded Semaglutide Injection starting at $149/mo and Tirzepatide Injection starting at $249/mo, both from licensed 503A compounding pharmacies. You can also explore the GLP-Squared Injection at $249/mo, which combines both compounds into one formulation for patients seeking a dual-receptor approach without switching medications. All treatments are available in all 50 states without insurance, and HSA/FSA contributions apply, making personalized GLP-1 or GIP+GLP-1 therapy accessible and affordable.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Does tirzepatide cause greater weight loss than semaglutide?

Clinical trials suggest tirzepatide may produce numerically higher weight reductions in some patient populations due to its dual-receptor mechanism, but individual results vary widely. Your genetic makeup, lifestyle, and adherence influence actual outcomes more than medication choice alone, which is why genetic testing can reveal your personal metabolic strengths.

Are Zepbound and Mounjaro the same as compounded semaglutide and tirzepatide?

Zepbound and Mounjaro are brand-name, FDA-approved versions manufactured by pharmaceutical companies. PlexusDx provides compounded semaglutide and tirzepatide from licensed 503A compounding pharmacies that produce pharmaceutical-grade compounds to exacting specifications. Both pathways deliver the active medications, but compounded options offer greater pricing flexibility and faster access without insurance requirements.

How much does PlexusDx tirzepatide cost compared to Mounjaro?

PlexusDx Tirzepatide Injection starts at $249/mo and remains flat regardless of your dose escalation—your dose may need to go up, but your price won't. This contrasts with many brand-name programs where costs increase as you titrate. PlexusDx serves all 50 states, requires no insurance or membership fees, and accepts HSA/FSA contributions.

What side effects should I expect with either medication?

Both semaglutide and tirzepatide commonly cause mild to moderate gastrointestinal effects, including nausea, constipation, and reduced appetite, especially during dose escalation. These typically diminish within 1–2 weeks as your body adjusts. Serious side effects are rare; discuss any persistent symptoms with your PlexusDx care team to optimize your protocol or adjust dosing.

Can the Precision Peptide Genetic Test predict which medication will work better for me?

Yes. PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) analyzes variants in GLP1R, GIPR, FTO, MC4R, and 10 other metabolic genes across 49 peptides. The test identifies your genetic predispositions to GLP-1 or GIP signaling efficiency, helping your care team optimize your prescription—whether that's semaglutide, tirzepatide, or the dual-compound GLP-Squared formula.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Wegovy Vs Zepbound Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.